RunPod
RunPod offers a robust cloud infrastructure designed for effortless deployment and scalability of AI workloads utilizing GPU-powered pods. By providing a diverse selection of NVIDIA GPUs, including options like the A100 and H100, RunPod ensures that machine learning models can be trained and deployed with high performance and minimal latency. The platform prioritizes user-friendliness, enabling users to create pods within seconds and adjust their scale dynamically to align with demand. Additionally, features such as autoscaling, real-time analytics, and serverless scaling contribute to making RunPod an excellent choice for startups, academic institutions, and large enterprises that require a flexible, powerful, and cost-effective environment for AI development and inference. Furthermore, this adaptability allows users to focus on innovation rather than infrastructure management.
Learn more
Vertex AI
Completely managed machine learning tools facilitate the rapid construction, deployment, and scaling of ML models tailored for various applications.
Vertex AI Workbench seamlessly integrates with BigQuery Dataproc and Spark, enabling users to create and execute ML models directly within BigQuery using standard SQL queries or spreadsheets; alternatively, datasets can be exported from BigQuery to Vertex AI Workbench for model execution. Additionally, Vertex Data Labeling offers a solution for generating precise labels that enhance data collection accuracy.
Furthermore, the Vertex AI Agent Builder allows developers to craft and launch sophisticated generative AI applications suitable for enterprise needs, supporting both no-code and code-based development. This versatility enables users to build AI agents by using natural language prompts or by connecting to frameworks like LangChain and LlamaIndex, thereby broadening the scope of AI application development.
Learn more
SYNTHIA Retrosynthesis Software
SYNTHIA™ Retrosynthesis software, created through the collaboration of computer scientists and chemists, empowers researchers to swiftly explore new and established pathways for target molecules. This tool enables efficient scanning of numerous pathways, helping to pinpoint the most suitable options tailored to specific requirements. With advanced visualization and filtering capabilities, users can uncover the most economical route to synthesize their desired molecule. The platform also allows for the customization of search parameters, enabling the user to either exclude or emphasize particular reactions, reagents, or molecular classes. Additionally, it presents innovative and distinctive synthetic routes to construct the target compound. Users can effortlessly generate a list of commercially available starting materials needed for their synthesis projects. Furthermore, the ISO/IEC 27001 Information Security Certification ensures the utmost confidentiality, integrity, and security of all data processed within the software, providing peace of mind to its users. This commitment to data protection reinforces the software's value in the scientific community.
Learn more
Recursion
Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.
Learn more
